Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 May;35(5):569-73.
doi: 10.1111/j.1365-3083.1992.tb03256.x.

Presence of CD16 on endothelial cells in heart transplant rejection: an immunohistochemical study

Affiliations

Presence of CD16 on endothelial cells in heart transplant rejection: an immunohistochemical study

W B Tuijnman et al. Scand J Immunol. 1992 May.

Abstract

We studied the distribution of Fc gamma RIII (CD16) in human lymphoid and non-lymphoid tissue by immunohistochemistry and two-colour immunofluorescence. In all tissues except stomach, skin, muscle and heart, infiltrating cells were stained. In tonsil and thymus, the CD16 antibody CLBgran 1 labelled some cells with high endothelial morphology in T-cell areas. Two-colour fluorescence combination of CD16 and antibody to Von Willebrand factor confirmed the endothelial nature of the CLB gran 1-positive cells. Fc gamma RIII expression was also demonstrated by antibody CLBgran11, which detects a product of the Fc gamma RIII-B gene of only the NA1 haplotype. A series of 95 endomyocardial biopsies (EMB) taken after heart transplantation was evaluated for Fc gamma RIII expression. In 18 cases Fc gamma RIII was unambiguously detected on endothelial cells by CD16 antibody CLBgran1. There was a significant correlation between capillary CD16 expression and transplant rejection. We conclude that Fc gamma R expression on endothelium represents endothelial activation found in immunopathological and inflammatory conditions.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources